Study of mice shows protein in womb plays lifelong role in bone health

January 30, 2017, University of Missouri-Columbia
(L to R) Laura Schulz, Ph.D., associate professor of obstetrics, gynecology and women's health; and Charlotte Phillips, Ph.D., associate professor of biochemistry and child health at the MU School of Medicine, are lead authors of the study. Credit: Justin Kelley, University of Missouri Health

Osteogenesis imperfecta, also known as brittle bone disease, is a genetic disorder that causes bones to break easily. Severe cases of the disease can result in hundreds of fractures during a person's lifetime or even death. Researchers at the University of Missouri School of Medicine have shown that limiting a specific maternal protein in pregnant mice with osteogenesis imperfecta resulted in offspring with stronger, denser bones. The finding might one day provide a new therapeutic approach to treating brittle bone disease.

"Osteogenesis imperfecta is caused by the body's inability to make strong bones because of mutations affecting the production of the protein known as collagen," said Charlotte Phillips, Ph.D., associate professor of biochemistry and child health at the MU School of Medicine and a senior author of the study. "No cure exists; however, we know from previous research that the prenatal environment can have a lasting effect on cardiovascular and metabolic health into adulthood. We studied whether health of mice could be improved by optimizing the environment within the womb."

Myostatin is a protein that limits muscle growth. However, exercise causes myostatin levels to decrease - which is good because it allows muscle tissue to develop, Phillips said. Increased muscle tissue results in stronger bones. In the study, Phillips and her team decreased maternal myostatin levels to see if this would increase in offspring with .

Using mice with , the MU researchers were able to identify the female as responsible for offspring bone health. The team also confirmed that deficient in myostatin had offspring with stronger bones.

"The third part of our study really confirmed our initial hypothesis," said Laura Schulz, Ph.D., associate professor of obstetrics, gynecology and women's health at the MU School of Medicine and a senior author of the study. "Fifty to 80 percent of bone density is predicted by genetics. To see if we could reverse this trend, we transplanted embryos from female mice with osteogenesis imperfecta into the wombs of female mice deficient in myostatin. The offspring from myostatin-deficient mothers with transplanted embryos had stronger, denser bones when they grew up than mice with the same genetic makeup from osteogenesis imperfecta females."

"Humans achieve 90 percent of their peak bone mass by age 19," Phillips said. "To approximate this timeframe with mice, we re-evaluated their bone strength and density four months after birth. In each case, the with stronger, denser adult bones were those whose fetal development involved females deficient in the protein myostatin. This finding shows that the environment within the womb affects bone development not only at birth, but into adulthood."

Both researchers believe that their work represents a paradigm shift in understanding and possibly treating osteogenesis imperfecta. The researchers also feel that their findings may prove beneficial to reducing the risk of other bone diseases such as osteoporosis later in life for many others. However, more research is needed.

"The intrauterine environment is important to ," Schulz said. "For parents with osteogenesis imperfecta, we may be able to reduce the severity of their unborn child's disease through prenatal treatment. This also may be true for reducing the instances and severity of other bone diseases."

The study, "Decreasing Maternal Myostatin Programs Adult Offspring Bone Strength in a Mouse Model of Osteogenesis Imperfecta," recently was published in Proceedings of the National Academy of Sciences.

Explore further: Study examines the effects of osteoporosis drugs in children with genetic bone disorders

More information: Arin K. Oestreich et al, Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1607644113

Related Stories

Study examines the effects of osteoporosis drugs in children with genetic bone disorders

January 9, 2017
Previous case reports in patients with osteogenesis imperfecta (OI) have suggested that treatment with bisphosphonates, which are commonly prescribed for osteoporosis, may be associated with atypical femur fractures. A new ...

New type of rare brittle-bone disease discovered

July 6, 2016
Researchers from the University of Zurich and University Children's Hospital Zurich have discovered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease. ...

New treatment for brittle bone disease found

August 9, 2013
A new treatment for children with brittle bone disease has been developed by the University of Sheffield and Sheffield Children's Hospital.

Gene discoveries give hope against 'Brittle bone' disease

May 8, 2013
(HealthDay)—Mutations in a gene involved in bone development appear to cause certain severe forms of bone loss, a finding that could lead to new therapies for the common bone-thinning disorder osteoporosis, researchers ...

C-section delivery does not decrease at-birth fracture rates in infants with rare bone disease

October 22, 2015
Cesarean delivery was not associated with decrease in the at-birth fracture rates in infants with osteogenesis imperfecta, a rare bone disorder, said a consortium of researchers led by Baylor College of Medicine.

Brittle bone disease: Drug research offers hope

March 31, 2015
New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating ...

Recommended for you

Deep space radiation treatment reboots brain's immune system

May 21, 2018
Planning a trip to Mars? You'll want to remember your anti-radiation pills.

Receptor proteins that respond to nicotine may help fat cells burn energy

May 21, 2018
The same proteins that moderate nicotine dependence in the brain may be involved in regulating metabolism by acting directly on certain types of fat cells, new research from the University of Michigan Life Sciences Institute ...

Atomic-level study reveals why rare disorder causes sudden paralysis

May 21, 2018
A rare genetic disorder in which people are suddenly overcome with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes, researchers at the University of ...

New era for blood transfusions through genome sequencing

May 18, 2018
Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group "antigens" on red blood cells—substances that can trigger the body's immune response—that differ from person to ...

Robots grow mini-organs from human stem cells

May 17, 2018
An automated system that uses robots has been designed to rapidly produce human mini-organs derived from stem cells. Researchers at the University of Washington School of Medicine in Seattle developed the new system.

Scientists uncover a new face of a famous protein, SWI2/SNF2 ATPase

May 17, 2018
A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.